The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Construction litigation for a general contractor
Represent a general contractor in complex litigation involving the construction of an approximately $13 million long-term, acute care hospital in more
Domain name dispute actions for multiple representative clients
The firm represented numerous trademark owners in domain name dispute actions arising under the Anti-Cybersquatting Consumer Protection Act and under more
Wage-Hour class action for major bottled water company
Represented a major North American bottled water company in a class action brought in Los Angeles County Superior Court. Plaintiffs filed a class more
Contested acquisition of CNB Financial Corporation
Represented CNB Financial Corporation in its contested acquisition. After executing a definitive agreement with Berkshire Hills Bancorp Inc., CNB more